Aarey Drugs & Pharmaceuticals Q2 Results FY27: Revenue Up 5.3% to Rs 88.62 Cr, PAT Rs 1.37 Cr

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Q2 Results FY27 announced on 14 November 2026, covering the company's financial performance for the July to September quarter. Revenue stood at Rs 88.62 Cr and PAT at Rs 1.37 Cr, which are the headline figures of Aarey Drugs & Pharmaceuticals Q2 Results FY27 for readers following the results date. These are standalone results, and every figure below is on that Standalone basis.

This Aarey Drugs & Pharmaceuticals Q2 Results analysis covers the financial highlights, the business drivers, the outlook and the risks. The results analysis begins with the Financial Highlights table, which sets this quarter against the same quarter last year, and then works through each section in the order a reader would ask about it.

Click Here – Get Free Investment Predictions

Aarey Drugs & Pharmaceuticals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 88.62 Cr	Rs 84.16 Cr	+5.3% YoY
Operating Profit	Rs 2.14 Cr	Rs 2.64 Cr	-18.94% YoY
Net Profit (PAT)	Rs 1.37 Cr	Rs 1.02 Cr	+34.31% YoY

Source: company filing for Aarey Drugs & Pharmaceuticals Q2 Results FY27, 14 November 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Aarey Drugs & Pharmaceuticals Q2 Results: What Stands Out

• Revenue: Revenue rose 5.3% YoY to Rs 88.62 Cr, against Rs 84.16 Cr in the same quarter of last year.
• Operating Profit: Operating Profit fell 18.94% YoY to Rs 2.14 Cr, compared with Rs 2.64 Cr a year earlier.
• Net profit: Net profit rose 34.31% YoY to Rs 1.37 Cr, so Aarey Drugs & Pharmaceuticals Q2 Results FY27 show profit moving against Operating Profit.
• Sequential revenue: Revenue was up 98.6% quarter on quarter from Rs 44.63 Cr, as the filing data shows.
• Next step: The performance analysis below shows how the YoY growth in revenue and net profit fit with the lower Operating Profit.

Aarey Drugs & Pharmaceuticals Q2 Results FY27: Performance Analysis

The figures in Aarey Drugs & Pharmaceuticals Q2 Results FY27 show revenue and net profit higher and Operating Profit lower than in the year-ago quarter. Revenue reached Rs 88.62 Cr against Rs 84.16 Cr, a gain of 5.3%, while net profit reached Rs 1.37 Cr against Rs 1.02 Cr, a gain of 34.31%.

In this results analysis, the gap between the rising net profit and the lower Operating Profit is the main point to register. Aarey Drugs & Pharmaceuticals Q2 Results FY27 record YoY growth of 5.3% in revenue, -18.94% in Operating Profit and 34.31% in net profit. Investors comparing the three lines will want to see how later quarterly results move.

Aarey Drugs & Pharmaceuticals Q2 Results also give a base for tracking the quarters that follow. Univest Screener lets readers line up the latest quarter against earlier ones, and the Univest app carries the same company data in one place. The results analysis now turns to the business factors listed in the filing data.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to revenue growth first. Revenue grew 5.3% year on year to Rs 88.62 Cr in the latest quarter, one of two lines among the quarterly results figures in Aarey Drugs & Pharmaceuticals Q2 Results FY27 that moved up.

Net Profit Growth – Net profit rose 34.3% year on year to Rs 1.37 Cr. This is a larger rise than the one in revenue, and the supplied data does not establish a specific cause for it.

Sequential Revenue – Revenue was up 98.6% quarter on quarter from Rs 44.63 Cr. This sequential view shows the previous quarter was much lower than the latest one.

FY27 Outlook After Aarey Drugs & Pharmaceuticals Q2 Results

FY27 full-year results will depend on the quarters still to be declared and on the conditions the company discloses. Aarey Drugs & Pharmaceuticals Q2 Results FY27 are one input into that picture, and this results analysis treats the quarter as a data point and not as a forecast for the rest of the year.

Net profit of Rs 1.37 Cr is the latest reading that investors can set against the year-ago Rs 1.02 Cr. Univest Screener shows how each later quarter compares, so the YoY pattern can be checked as new filings arrive. The next section turns from the outlook to the risks that the filing data highlights.

Key Risks to Watch After Aarey Drugs & Pharmaceuticals Q2 Results FY27

Low Return on Equity

Return on equity was low at 2.81% in FY26. This is an annual ratio, and later quarterly results will show how YoY growth in profit develops against it.

Modest Return on Capital Employed

Return on capital employed was modest at 5.57% in FY26. Aarey Drugs & Pharmaceuticals Q2 Results FY27 should be read alongside this annual figure, since it describes the full year and not the July to September period.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 0.57 Cr to Rs 1.56 Cr over the last 5 quarters. The latest Rs 1.37 Cr sits inside that range.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Aarey Drugs & Pharmaceuticals Q2 Results FY27 show revenue of Rs 88.62 Cr, up YoY, and net profit of Rs 1.37 Cr, also up YoY, on a Standalone basis. The quarterly results also show Operating Profit at Rs 2.14 Cr, so these standalone results need the annual ratios and the volatility alongside the growth. Readers can study Aarey Drugs & Pharmaceuticals Q2 Results alongside earlier filings. Investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Aarey Drugs & Pharmaceuticals Q2 Results FY27

What are Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Aarey Drugs & Pharmaceuticals Q2 Results FY27 are the July to September 2026 quarterly results, declared on 14 November 2026. They show revenue of Rs 88.62 Cr and net profit of Rs 1.37 Cr, as the Financial Highlights table shows.

What is the results date for Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Aarey Drugs & Pharmaceuticals declared its Q2 FY27 results on 14 November 2026, covering July to September 2026. This results date anchors the YoY comparison, which the Key Takeaways section sets out against last year.

What revenue was reported in Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Aarey Drugs & Pharmaceuticals reported revenue of Rs 88.62 Cr for Q2 FY27, compared with Rs 84.16 Cr a year earlier. This means revenue moved up, as the Performance Analysis section explains in more detail.

What net profit was reported in Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Aarey Drugs & Pharmaceuticals reported net profit of Rs 1.37 Cr for Q2 FY27, against Rs 1.02 Cr in the year-ago quarter. Alongside this, the Financial Highlights table shows the same two figures.

How much YoY growth did revenue show in Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Revenue showed YoY growth of 5.3% in Q2 FY27, rising to Rs 88.62 Cr from Rs 84.16 Cr. Compared with net profit growth of 34.31%, net profit grew faster, as the Performance Analysis shows.

Did net profit rise or fall in Aarey Drugs & Pharmaceuticals Q2 Results?

Ans. Net profit rose in the Q2 FY27 quarter of Aarey Drugs & Pharmaceuticals, up 34.31% YoY to Rs 1.37 Cr from Rs 1.02 Cr. Alongside this, revenue rose 5.3%, which the Key Takeaways section sets out.

What was the Operating Profit in Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. Aarey Drugs & Pharmaceuticals reported Operating Profit of Rs 2.14 Cr, against Rs 2.64 Cr a year earlier, a YoY growth of -18.94%. This differs from the net profit move, as the Performance Analysis explains.

Are Aarey Drugs & Pharmaceuticals Q2 Results consolidated results or standalone results?

Ans. These are standalone results, and every figure for Aarey Drugs & Pharmaceuticals in this article is on a Standalone basis. Alongside this, the Financial Highlights table shows the same basis for both quarters compared.

What business factors shaped Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. The filing data lists revenue growth of 5.3%, net profit growth of 34.3% and revenue up 98.6% quarter on quarter. Alongside this, the Key Business Factors section explains each one.

What are the key risks after Aarey Drugs & Pharmaceuticals Q2 Results FY27?

Ans. The risks listed are return on equity of 2.81%, return on capital employed of 5.57% and volatile quarterly net profit. These are covered in the Key Risks section, with YoY growth in context.

What is the outlook after Aarey Drugs & Pharmaceuticals Q2 Results?

Ans. FY27 full-year results for Aarey Drugs & Pharmaceuticals will depend on the quarters still to be declared, so this quarter is a data point and not a forecast. The FY27 Outlook section sets out that view.

Where can I find the complete Aarey Drugs & Pharmaceuticals Q2 Results FY27 data?

Ans. The complete data sits in the Financial Highlights table of this article, which lists revenue and net profit with YoY change. Alongside this, Univest Screener carries the same company data for later quarters.